Cargando…
PB2627: THROMBOTIC THROMBOCYTOPENIC PURPURA, RELAPSE RELATED RISK FACTORS IN A CARE CENTER WITH LIMITED ACCESS TO ADAMTS13 LEVELS.
Autores principales: | Goya, Santiago Riviello, Rodriguez-Rodriguez, Sergio, Meza-Meza, Mario, Ontiveros-Austria, Juan Luis, Tuna-Aguilar, Elena, Demichelis-Gomez, Roberta, Inclan-Alarcon, Sergio I, Apodaca-Chavez, Elia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429379/ http://dx.doi.org/10.1097/01.HS9.0000977196.19287.e8 |
Ejemplares similares
-
Recombinant ADAMTS 13 in thrombotic thrombocytopenic purpura
por: Scully, Marie, et al.
Publicado: (2017) -
A case of antisynthetase syndrome with thrombotic thrombocytopenic purpura
por: Goreshnik, Ashley, et al.
Publicado: (2020) -
Shared decision making, thrombotic thrombocytopenic purpura, and caplacizumab
por: Sukumar, Senthil, et al.
Publicado: (2020) -
Prasugrel and Acquired Thrombotic Thrombocytopenic Purpura Associated with ADAMTS13 Activity Deficiency
por: Lopez, Yanet Parodis, et al.
Publicado: (2016) -
ADAMTS13 and Non-ADAMTS13 Biomarkers in Immune-Mediated Thrombotic Thrombocytopenic Purpura
por: Bonnez, Quintijn, et al.
Publicado: (2023)